Satellos Bioscience Stock Price, News & Analysis
Company Description
Satellos Bioscience (NASDAQ: MSLE) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $127.7M, ranking #4,862 among all listed U.S. companies by market cap.
MSLE stock has declined 47.5% over the past year. Shares last traded at $5.91.
This page provides a comprehensive overview of MSLE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Satellos Bioscience (MSLE) stock last traded at $5.91, down 3.63% from the previous close. Over the past 12 months, the stock has lost 47.5%. At a market capitalization of $127.7M, MSLE is classified as a micro-cap stock with approximately 20.6M shares outstanding.
Latest News
Satellos Bioscience has 9 recent news articles, with the latest published 3 days ago. Of the recent coverage, 1 article coincided with positive price movement and 7 with negative movement. Key topics include earnings, conferences, clinical trial, offering. View all MSLE news →
SEC Filings
Satellos Bioscience has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form 40-F. The most recent filing was submitted on March 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MSLE SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MSLE Company Profile & Sector Positioning
Satellos Bioscience (MSLE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.